Avricore Health Corporate Update: Effective Plan, Resources Result in Success
29 nov. 2024 07h30 HE
|
Avricore Health Inc.
Avricore Health Inc. (AVCR) releases its third-quarter results.
Avricore Health Refocuses Strategy to Unlock Growth Potential
14 nov. 2024 18h01 HE
|
Avricore Health Inc.
Avricore Health (AVCR) makes a strategic shift to focus on UK market where it expects to take advantage of better market conditions.
Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch
06 nov. 2024 15h14 HE
|
Avricore Health Inc.
Avricore earned 8th spot in Deloitte Canada’s 2024 Technology Fast 50™ Companies-to-Watch list, reflecting its significant growth.
Avricore Grants Options
30 août 2024 21h29 HE
|
Avricore Health Inc.
Avricore Health issues stock options in accordance with plan.
Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability
29 août 2024 06h05 HE
|
Avricore Health Inc.
Avricore Health Inc. reports mid-year results demonstrating strong growth, second consecutive quarter of profitability.
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
03 juin 2024 08h00 HE
|
Avricore Health Inc.
Q1 2024 Results
Avricore Health Corporate Update and Audited Results for 2023
30 avr. 2024 06h00 HE
|
Avricore Health Inc.
2023 audited financials show a near doubling of revenues and a strong growth trajectory.
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
04 avr. 2024 07h30 HE
|
Avricore Health Inc.
Avriciore's HelathTab platform for point-of-care testing in pharmacy expands Rexall locations.
Avricore Health Corporate Update – Company Demonstrates Strong Growth
30 nov. 2023 12h58 HE
|
Avricore Health Inc.
Avricore Health provides a corporate update and results for the first 9 months of 2023.
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic
15 sept. 2023 12h53 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic...